^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
GENE:

MRPS11 (Mitochondrial Ribosomal Protein S11)

i
Other names: MRPS11, Mitochondrial Ribosomal Protein S11, HCC-2, Mitochondrial Small Ribosomal Subunit Protein US11m, 28S Ribosomal Protein S11, Mitochondrial, Cervical Cancer Proto-Oncogene 2 Protein, FLJ23406, FLJ22512, MRP-S11, S11mt, Cervical Cancer Proto-Oncogene 2, RPMS11
Associations
Trials
over1year
Identification and validation of a prognostic model based on immune-related genes in ovarian carcinoma. (PubMed, PeerJ)
The analyses of genetic status of patients with 25-genes model might improve the ability to predict the prognosis of patients with OC and help to select patients suit able to therapies. Immune-related gene GBP1P1 might serve as prognostic biomarker for OC.
Journal
|
IGF2BP1 (Insulin Like Growth Factor 2 MRNA Binding Protein 1) • GBP1 (Guanylate Binding Protein 1) • FZD3 (Frizzled Class Receptor 3) • MRPS11 (Mitochondrial Ribosomal Protein S11) • TNFAIP8 (TNF Alpha Induced Protein 8) • BMPR1B (Bone Morphogenetic Protein Receptor Type 1B) • KIF26B (Kinesin Family Member 26B)
over3years
Novel LncRNA ZFHX4-AS1 as a Potential Prognostic Biomarker That Affects the Immune Microenvironment in Ovarian Cancer. (PubMed, Front Oncol)
Knockdown of lncRNA ZFHX4-AS1 could inhibit the proliferation, invasion and migration of OvCa cells. The results suggested that lncRNA ZFHX4-AS1 is a novel prognostic biomarker associated with cell proliferation, metabolism, infiltration, and distribution of tumor-infiltrating immune cells in OvCa, indicating that lncRNA ZFHX4-AS1 can be used as a potential therapeutic target for OvCa in the future.
Journal
|
MRPS11 (Mitochondrial Ribosomal Protein S11)